PRCT — PROCEPT BioRobotics Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1588978 ·
Last close
$23.22
Market Cap
$1.32B
52W High
$29.74
52W Low
$21.28
ADV30
1,484,860
Next earnings
2026-04-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 83,132,000 | 53,947,000 | -32,606,000 | -31,638,000 | 487,062,000 | 245,641,000 | 139,395,000 |
| Dec 2025 | 76,383,000 | 46,313,000 | -31,041,000 | -29,845,000 | 508,081,000 | 286,503,000 | 142,211,000 |
| Sep 2025 | 83,327,000 | 54,006,000 | -23,192,000 | -21,411,000 | 511,541,000 | 294,281,000 | 131,265,000 |
| Jun 2025 | 79,182,000 | 51,746,000 | -22,189,000 | -19,578,000 | 513,054,000 | 302,717,000 | 127,258,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,132,000
Investing CF
$-10,434,000
Financing CF
$10,117,000
CapEx
$-10,434,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.82
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-673,195,000
Inventory
$77,536,000
Receivables
$96,388,000
ST Investments
—
EBIT TTM
$-98,799,000
Pretax Income TTM
$-102,325,000
Interest Exp TTM
$3,526,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$322,024,000
EBITDA
$-102,377,000
Free Cash Flow
$-43,175,248
Enterprise Value
$1,295,453,824
Total Cash
$245,640,992
Total Debt
$77,996,000
Shares Out
56,918,844
Trailing EPS
$-1.83
Book Value
$6.11
ROE
-27.8%
ROA
-13.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 308,054,000 | -103,859,000 | -95,572,000 | 508,081,000 | 142,211,000 | — | -48,985,000 |
| Dec 2024 | 224,498,000 | -96,614,000 | -91,413,000 | 534,017,000 | 131,797,000 | — | -99,213,000 |
| Dec 2023 | 136,191,000 | -109,170,000 | -105,897,000 | 404,717,000 | 123,965,000 | — | -108,003,000 |
| Dec 2022 | 75,014,000 | -80,724,000 | -87,154,000 | 309,329,000 | 112,257,000 | — | -80,382,000 |
TTM Snapshot
Revenues TTM
$122,489,000
NetIncome TTM
$-82,312,000
OpCashFlow TTM
$0
Assets (Latest)
$534,017,000
Forward EPS
$-0.87
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc. | $1.32B | $5.63 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.30B | $26.69 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.36B | $17.46 | — |
| ATEC | Alphatec Holdings, Inc. | $1.27B | $8.29 | — |
| CDRE | Cadre Holdings, Inc. | $1.24B | $29.09 | — |
News headlines (Yahoo Finance, 1h cache)
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
2026-06-11 13:38 · Yahoo
Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
2026-06-11 12:04 · Yahoo
JenaValve Appoints Matt Bacso as Chief Financial Officer
2026-06-10 13:00 · Yahoo
PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's Changed
2026-06-01 01:04 · Yahoo
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
2026-05-28 12:00 · Yahoo
Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)
2026-05-26 12:08 · Yahoo
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
2026-05-23 20:37 · Yahoo
5 Robotics Stocks to Watch as Physical AI Builds Momentum
2026-05-18 15:20 · Yahoo
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
2026-05-14 12:00 · Yahoo
Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock Outlook
2026-05-12 18:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.